Graham Capital Management, L.P.

Position in ARVN — Arvinas, Inc.

CIK 1315421 ROWAYTON, CT

Position in ARVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$676,134

+$560,573 QoQ

Shares Held

81,364

+646.3% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#69

of 198 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. ARVN ranks #6 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc. This page	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$676,134	81,364	+646.3%	Shares	Sole	2026-08-14
2026-03-31	$115,561	10,902	-10.2%	Shares	Sole	2026-05-15
2025-12-31	$144,015	12,143	-86.1%	Shares	Sole	2026-02-17
2025-09-30	$744,724	87,409	-62.7%	Shares	Sole	2025-11-14
2025-06-30	$1,726,862	234,628	-22.1%	Shares	Sole	2025-08-14
2025-03-31	$2,115,154	301,304	+242.9%	Shares	Sole	2025-05-15
2024-12-31	$1,684,640	87,879	+38.2%	Shares	Sole	2025-02-14
2024-09-30	$1,565,876	63,576	-0.8%	Shares	Sole	2024-11-14
2024-06-30	$1,706,501	64,106	+276.1%	Shares	Sole	2024-08-14
2024-03-31	$703,576	17,044	+145.8%	Shares	Sole	2024-05-15
2022-09-30	$308,493	6,934	-47.8%	Shares	Sole	2022-11-14
2022-06-30	$559,376	13,290	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.